Evidence map›Paper›PMID 31661825›Full record

ArticlePathogens (Basel, Switzerland)2019

Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana.

Tuelo Mogashoa, Pinkie Melamu, Brigitta Derendinger, Serej D Ley, Elizabeth M Streicher, Thato Iketleng, Lucy Mupfumi, Margaret Mokomane, Botshelo Kgwaadira, Goabaone Rankgoane-Pono and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Pathogens (Basel, Switzerland) · 2020
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Tuelo MogashoaDepartment of Medical Laboratory Sciences, Faculty of Health Sciences, University of Botswana, Gaborone 0022, Botswana. tuelomogashoa@me.com.ORCID 0000-0003-4156-8746
Pinkie MelamuBotswana Harvard AIDS Institute Partnership, Gaborone 0000, Botswana. pmpmelamu@gmail.com.
Brigitta DerendingerDST-NRF Centre of Excellence in Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, Cape Town 7505, South Africa. brigitta@sun.ac.za.
Serej D LeyDST-NRF Centre of Excellence in Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, Cape Town 7505, South Africa. 21280606@sun.ac.za.ORCID 0000-0002-2705-9120
Elizabeth M StreicherDST-NRF Centre of Excellence in Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, Cape Town 7505, South Africa. lizma@sun.ac.za.
Thato IketlengBotswana Harvard AIDS Institute Partnership, Gaborone 0000, Botswana. iketlengt@gmail.com.ORCID 0000-0002-5725-295X
Lucy MupfumiDepartment of Medical Laboratory Sciences, Faculty of Health Sciences, University of Botswana, Gaborone 0022, Botswana. lmupfumi@gmail.com.
Margaret MokomaneNational Tuberculosis Reference Laboratory, Ministry of Health and Wellness, Gaborone 0000, Botswana. bafanamargaret@gmail.com.
Botshelo KgwaadiraBotswana National Tuberculosis Programme, Ministry of Health and Wellness, Gaborone 0000, Botswana. btkgwaadira@gmail.com.
Goabaone Rankgoane-PonoBotswana National Tuberculosis Programme, Ministry of Health and Wellness, Gaborone 0000, Botswana. goaba2000@yahoo.com.
Thusoyaone T TsholofeloBotswana National Tuberculosis Programme, Ministry of Health and Wellness, Gaborone 0000, Botswana. ttsholo808@gmail.com.
Ishmael KasvosveDepartment of Medical Laboratory Sciences, Faculty of Health Sciences, University of Botswana, Gaborone 0022, Botswana. kasvosvei@ub.ac.bw.ORCID 0000-0002-2046-545X
Sikhulile MoyoBotswana Harvard AIDS Institute Partnership, Gaborone 0000, Botswana. sikhulilemoyo@gmail.com.ORCID 0000-0003-3821-4592
Robin M WarrenDST-NRF Centre of Excellence in Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, Cape Town 7505, South Africa. rw1@sun.ac.za.
Simani GaseitsiweBotswana Harvard AIDS Institute Partnership, Gaborone 0000, Botswana. sgaseitsiwe@bhp.org.bw.
Ministry of Health · BWSouth African Medical Research Council · ZAUniversity of Botswana · BWBotswana Harvard AIDS Institute Partnership · BWHarvard University · US

Funding

Sub-Saharan African Network for TB/HIV Research Excellence DEL-15-006 and 107752/Z/15/Z
6 · The paper itself

Abstract

The emergence and transmission of multidrug resistant (MDR) and extensively drug resistant (XDR)

Indexed as

drug resistanceline probe assayMDR-TBMycobacterium tuberculosissecond-line drugsXDR-TB

Identifiers

PMID31661825
PMCPMC6963291
OpenAlexW2981708751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.